LKF Laboratorium fuer Klinische Forschung GmbH performs laboratory testing and evaluation of sample material for scientific studies, medical-diagnostic questions and clinical-pharmacological trials. The company handles logistics, import, documentation and storage of samples and provides contract research services for national and international pharmaceutical companies. The order portfolio comprises a few large and many medium and small pharmaceutical companies; in fiscal year 2017 the revenue increase was driven mainly by higher sales from the largest customer. The company positions itself as a flexible service provider with fast response times, reported revenue of T€ 14,873 and assesses its asset, financial and earnings position as good.
Die Erstellung von Laboranalysen im Rahmen wissenschaftlicher Untersuchungen, medizin-diagnostischer Fragestellungen sowie klinisch-pharmakologischer Prüfungen
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Kiel Local Court, HRB 2150 (as of 2 November 2026)
| Name | Type | City |
|---|---|---|
| Volker El-Samalouti | Geschäftsführer(in) | Kiel |
| Gerrit Schönicke | Geschäftsführer(in) | Heikendorf |
Source: German Commercial Register (Handelsregister) Kiel Local Court, HRB 2150 (as of 2 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2017 | Rohergebnis€8.3M2 | €1,317,529 | €11,931,090 | — |
| 2016 | Rohergebnis€5.9M2 | €505,859 | €8,361,346 | — |
| 2015 | Rohergebnis€5.9M2 | €588,525 | €8,093,523 | — |
| 2014 | Rohergebnis€8.3M2 | €630,602 | €8,317,830 | — |
| 2013 | Rohergebnis€7.9M2 | €410,429 | €8,196,867 | — |
| 2012 | Rohergebnis€9M2 | €786,324 | €8,628,243 | — |
| 2011 | Rohergebnis€8.2M2 | €623,774 | €8,107,736 | — |
| 2010 | Rohergebnis€8.1M2 | €960,095 | €8,133,612 | — |
| 2009 | Rohergebnis€8.3M2 | €1,453,242 | €7,355,605 | — |
| 2008 | Rohergebnis€9M2 | €1,813,240 | €6,677,270 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Kiel Local Court, HRB 2150 (as of 2 November 2026)
Klinikum Merzig gGmbH
Merzig · Krankenhäuser (ohne Hochschulkliniken, Vorsorge- und Rehabilitationskliniken)
NVision Quantum Technologies GmbH
Ulm · Erbringung von Dienstleistungen der diagnostischen Bildgebung
MLL Münchner Leukämielabor GmbH
München · Erbringung von Dienstleistungen von medizinischen Laboratorien
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €4,717,145 | 94.9% |
| Depreciation | €240,008 | 4.8% |
| Interest & Similar | €12,461 | 0.3% |
